J9273 Injection tisotu vedotin-tftv, 1mg
Also known as: tisotumab vedotin, Tivdak
Injection of tisotumab vedotin-tftv, 1 milligram. An antibody-drug conjugate targeting tissue factor with a microtubule-disrupting cytotoxic payload.
In Plain Language
targeted cancer injection; antibody-drug combination
Clinical Context
Used for cervical cancer and other solid tumors expressing tissue factor. Provides durable response in recurrent and metastatic disease.
RVU Information
CPT J9273 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9273?
CPT J9273 (Injection tisotu vedotin-tftv, 1mg) is a J Codes (Drugs) code. Injection of tisotumab vedotin-tftv, 1 milligram. An antibody-drug conjugate targeting tissue factor with a microtubule-disrupting cytotoxic payload.
How is J9273 administered?
CPT J9273 is administered by a healthcare provider, typically via injection or infusion. Used for cervical cancer and other solid tumors expressing tissue factor. Provides durable response in recurrent and metastatic disease. It is used by Oncology, Gynecology, Urology.
When is CPT J9273 used?
Used for cervical cancer and other solid tumors expressing tissue factor. Provides durable response in recurrent and metastatic disease.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.